Madrigal Pharmaceuticals (MDGL) Gains from Investment Securities (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) reported Gains from Investment Securities of $2.4 million for Q1 2026, down 38.72% on a QoQ basis from $4.0 million in Q2 2025.
Madrigal Pharmaceuticals (MDGL) has 15 years of Gains from Investment Securities data on file, last reported at $2.4 million in Q1 2026.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (up 368.08% YoY) and the FY2025 annual result came in at $4.0 million, up 206.31% from the prior year.
- Gains from Investment Securities declined to $2.4 million in Q1 2026 per MDGL's latest filing, from $4.0 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $4.0 million in Q2 2025 and bottomed at -$28000.0 in Q4 2023.
- The 4-year median for Gains from Investment Securities is $1.4 million (2023), against an average of $1.6 million.
- Peak annual rise in Gains from Investment Securities reached 814.29% in 2024, while the deepest fall reached 26.29% in 2024.
- Tracing MDGL's Gains from Investment Securities over 4 years: stood at -$28000.0 in 2023, then surged by 814.29% to $200000.0 in 2024, then jumped by 1891.0% to $4.0 million in 2025, then sank by 38.72% to $2.4 million in 2026.
- Per Business Quant, the three latest MDGL Gains from Investment Securities figures stand at $2.4 million (Q1 2026), $4.0 million (Q2 2025), and $200000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Madrigal Pharmaceuticals | 14.44 Bn | 14.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.44 Mn |
| Mar 31, 2026 | 2.44 Mn |
| Jun 30, 2025 | 3.98 Mn |
| Jun 30, 2025 | 3.98 Mn |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Dec 31, 2023 | -28,000.00 |
| Dec 31, 2023 | -28,000.00 |
| Sep 30, 2023 | 1.63 Mn |
| Sep 30, 2023 | 1.63 Mn |
| Sep 30, 2020 | 451,000.00 |
| Sep 30, 2020 | 451,000.00 |
| Mar 31, 2019 | 958,345.00 |
| Mar 31, 2019 | 958,345.00 |
| Dec 31, 2018 | 1.13 Mn |
| Dec 31, 2018 | 1.13 Mn |
| Sep 30, 2018 | 1.23 Mn |
| Sep 30, 2018 | 1.23 Mn |
| Jun 30, 2018 | 1.14 Mn |
| Jun 30, 2018 | 1.14 Mn |
| Mar 31, 2018 | 1.29 Mn |
| Mar 31, 2018 | 1.29 Mn |
| Dec 31, 2017 | 976,777.00 |
| Dec 31, 2017 | 976,777.00 |
| Sep 30, 2017 | 1.44 Mn |
| Sep 30, 2017 | 1.44 Mn |
| Jun 30, 2017 | 1.46 Mn |
| Jun 30, 2017 | 1.46 Mn |
| Mar 31, 2017 | 141,000.00 |
| Mar 31, 2017 | 141,000.00 |
| Dec 31, 2016 | 784,011.00 |
| Dec 31, 2016 | 784,011.00 |
| Sep 30, 2016 | 772,410.00 |
| Sep 30, 2016 | 772,410.00 |
| Jun 30, 2016 | 91,000.00 |
| Jun 30, 2016 | 91,000.00 |
| Mar 31, 2016 | 17,857.00 |
| Mar 31, 2016 | 17,857.00 |
| Dec 31, 2015 | -226,000.00 |
| Dec 31, 2015 | -226,000.00 |
| Sep 30, 2015 | 9.59 Mn |
| Sep 30, 2015 | 9.59 Mn |
| Jun 30, 2015 | 8.74 Mn |
| Jun 30, 2015 | 8.74 Mn |
| Mar 31, 2015 | 259,000.00 |
| Mar 31, 2015 | 259,000.00 |
| Dec 31, 2014 | -26,000.00 |
| Dec 31, 2014 | -26,000.00 |
| Sep 30, 2014 | 1.28 Mn |
| Sep 30, 2014 | 1.28 Mn |
| Jun 30, 2014 | 756,353.00 |
| Jun 30, 2014 | 756,353.00 |
| Mar 31, 2014 | -32,000.00 |
| Mar 31, 2014 | -32,000.00 |
| Dec 31, 2013 | 151,000.00 |
| Dec 31, 2013 | 151,000.00 |
| Sep 30, 2013 | 6.74 Mn |
| Sep 30, 2013 | 6.74 Mn |
| Jun 30, 2013 | 430,860.00 |
| Jun 30, 2013 | 430,860.00 |
| Mar 31, 2013 | 16,152.00 |
| Mar 31, 2013 | 16,152.00 |
| Dec 31, 2012 | 5.52 Mn |
| Dec 31, 2012 | 5.52 Mn |
| Sep 30, 2012 | 1.74 Mn |
| Sep 30, 2012 | 1.74 Mn |
| Jun 30, 2012 | 25,000.00 |
| Jun 30, 2012 | 25,000.00 |
| Mar 31, 2012 | -112,000.00 |
| Mar 31, 2012 | -112,000.00 |
| Dec 31, 2011 | 101,000.00 |
| Dec 31, 2011 | 101,000.00 |
| Sep 30, 2011 | 33,000.00 |
| Sep 30, 2011 | 33,000.00 |
| Jun 30, 2011 | 80,000.00 |
| Jun 30, 2011 | 80,000.00 |
| Mar 31, 2011 | 51,000.00 |
| Mar 31, 2011 | 51,000.00 |
| Dec 31, 2010 | -95,000.00 |
| Dec 31, 2010 | -95,000.00 |
| Sep 30, 2010 | 310,000.00 |
| Sep 30, 2010 | 310,000.00 |